COLUMBUS, Georgia. And SEATTLE, December 4, 2023 /PRNewswire/ — Aflac Incorporated (NYSE: AFL), a Fortune 500 company and leading provider of supplemental health insurance in Japan And United Statesand Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, jointly announce Trupanion’s renewal of an S-3 registration statement on December 1, 2023. This measure is taken in accordance with the shareholders’ agreement concluded between the two companies on October 26, 2020 and renews the S-3 registration statement filed on December 1, 2020.
Aflac and Trupanion reaffirm their shared commitment to the continued success of the partnership. This commitment highlights their mutual commitment to unlocking the significant long-term potential of the category and their confidence in the products offered by Trupanion, the largest provider of pet medical insurance in North America.
About Aflac Incorporated
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind to millions of policyholders and customers for more than 68 years through its subsidiaries in the United States and Japan. In the United States, Aflac is the leading provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading cancer and medical insurance provider in terms of in-force policies. The company is proud to be there for its policyholders when they need us most, and to be included in 2023 among the World’s Most Ethical Companies by Ethisphere for 17 consecutive years, among the Most Admired Companies in the World. Fortune World for 22 years and in the Bloomberg Gender Equality Index. for the fourth consecutive year. Additionally, the Company became a signatory to the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2022) for nine years. To find out how to get help for expenses not covered by health insurance, learn more about us at aflac.com or aflac.com/espanol. Investors can learn more about Aflac Incorporated and the company’s commitment to corporate social responsibility and sustainability at investors.aflac.com under “Sustainability”.
1 U.S. Supplemental Health Insurance Total Market Report LIMRA 2022
About Trupanion
Trupanion is a leader in medical insurance for cats and dogs everywhere United States, Canada, Europe, Porto Rico And Australia with more than 960,000 animals registered. For over two decades, Trupanion has provided pet owners with peace of mind so they can focus on their pet’s recovery, not financial stress. Trupanion is committed to providing pet parents with the highest value in pet medical insurance, with unlimited payments for the life of their pets. Through its patented process, Trupanion is the only North American provider with the technology to pay veterinarians directly in seconds at checkout. Trupanion is listed on NASDAQ under the symbol “TRUP”. The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in United Statesthrough its wholly owned insurance company American Pet Insurance Company and, in Canada, by Omega General Insurance Company. Trupanion Australia is a partnership between Trupanion and Hollard Insurance Company. For more information, please visit trupanion.com.
Forward-looking statements
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding, among other things, expectations, plans, prospects and financial results of Trupanion, including, but not limited to, the success of the Aflac partnership and its ability to generate long-term value, its expectations regarding its ability to continue to grow its enrollment and revenue, and to execute its business plan. These forward-looking statements are based on the current expectations and beliefs of Trupanion’s management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the statements. prospective. . Any forward-looking statements made in this press release are based on information available to Trupanion as of the date hereof, and Trupanion undertakes no obligation to update these forward-looking statements. In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: the ability to achieve or maintain profitability and/or appropriate levels of cash flow in future periods; the ability to continue to grow our membership base and revenue; the accuracy of the assumptions used to determine appropriate member acquisition expenses; the severity and frequency of complaints; the ability to maintain high retention rates; the accuracy of assumptions used in pricing medical plan subscriptions and the ability to accurately estimate the impact of new products or offerings on claims frequency; actual claims expenses exceeding estimates; regulatory and other constraints on the ability to institute, or otherwise delay, pricing changes in response to changes in actual or estimated claims expenses; the effectiveness and statutory or regulatory compliance of our territory partner model and our territory partners, veterinarians and other third parties in recommending medical plan subscriptions to prospective members; the ability to retain existing territorial partners and increase the number of territorial partners and active hospitals; compliance by us and those who refer members to us with the laws and regulations that apply to our business, including the sale of a pet medical plan; the ability to maintain the security of our data; fluctuations in the exchange rate of the Canadian currency; the ability to protect our proprietary information and that of our members; the ability to maintain our culture and our team; the ability to maintain the required amount of capital based on risk; our ability to implement and maintain effective controls, including over financial reporting; the ability to protect and enforce Trupanion’s intellectual property rights; the ability to successfully implement our alliance with Aflac; the ability to pursue key contractual relationships with third parties; third party claims, including litigation and regulatory actions; the ability to recognize the benefits of investments in new solutions and enhancements to Trupanion’s technology platform and website; and our ability to retain key personnel. For a detailed discussion of these and other cautionary statements, please refer to the risk factors discussed in filings with the Securities and Exchange Commission (SEC), including, but not limited to, the Annual Report of Trupanion on Form 10-K for the year ended. December 31, 2022 and all reports subsequently filed on Forms 10-Q, 10-K and 8-K. All documents are available through the SEC’s Electronic Data Analysis and Retrieval System at https://www.sec.gov or the Investor Relations section of Trupanion’s website at https://investors.trupanion.com.
Contacts
Trupanion Investor Relations – Laura Bainbridge, (email protected)
Aflac analyst and investor contact – David A. Young, 706.596.3264; 800.235.2667 or (email protected)
Aflac Media Contact – Inès Gutzmer762.207.7601 or (email protected)
SOURCE Aflac Incorporated